Literature DB >> 10608596

Pharmacologic stress testing: understanding the options.

M P White1.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10608596     DOI： 10.1016/s1071-3581(99)90105-8

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  10 in total

1.  Usefulness of high-dose dipyridamole echocardiography test in coronary angioplasty.

Authors:  E Picano; S Pirelli; M Marzilli; F Faletra; F Lattanzi; L Campolo; D Massa; A Alberti; E Gara; A Distante
Journal:  Circulation       Date:  1989-10       Impact factor: 29.690

2.  Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients.

Authors:  A S Iskandrian; J Heo; B Kong; E Lyons
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

3.  Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.

Authors:  M G Levine; A W Ahlberg; A Mann; M P White; C C McGill; C Mendes de Leon; J M Piriz; D Waters; G V Heller
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 5.952

4.  Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging in coronary artery disease.

Authors:  G Jamil; A W Ahlberg; M D Elliott; R C Hendel; T Holly; C C McGill; M Sarkis; M P White; J F Mather; D D Waters; G V Heller
Journal:  Am J Cardiol       Date:  1999-08-15       Impact factor: 2.778

5.  Impact of acute propranolol administration on dobutamine-induced myocardial ischemia as evaluated by myocardial perfusion imaging and echocardiography.

Authors:  A R Shehata; L D Gillam; V A Mascitelli; S D Herman; A W Ahlberg; M P White; C Chen; D D Waters; G V Heller
Journal:  Am J Cardiol       Date:  1997-08-01       Impact factor: 2.778

6.  Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study.

Authors:  J Lette; J L Tatum; S Fraser; D D Miller; D D Waters; G Heller; E B Stanton; H S Bom; J Leppo; S Nattel
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

7.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.

Authors:  M D Cerqueira; M S Verani; M Schwaiger; J Heo; A S Iskandrian
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

8.  Safety of dobutamine stress for thallium-201 myocardial perfusion tomography in patients with asthma.

Authors:  D J Pennell; S R Underwood; P J Ell
Journal:  Am J Cardiol       Date:  1993-06-01       Impact factor: 2.778

9.  The physiologic basis of dobutamine as compared with dipyridamole stress interventions in the assessment of critical coronary stenosis.

Authors:  A Y Fung; K P Gallagher; A J Buda
Journal:  Circulation       Date:  1987-10       Impact factor: 29.690

10.  Symptom-limited arm exercise increases detection of ischemia during dipyridamole tomographic thallium stress testing in patients with coronary artery disease.

Authors:  L Stein; R Burt; B Oppenheim; D Schauwecker; N Fineberg
Journal:  Am J Cardiol       Date:  1995-03-15       Impact factor: 2.778
  10 in total
  2 in total

1.  Safety and feasibility of atropine added to submaximal exercise stress testing with Tl-201 SPECT for the diagnosis of myocardial ischemia.

Authors:  Sanjay K Prasad; Dudley J Pennell
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

2.  Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT.

Authors:  Filippo Maria Sarullo; Corrado Ventimiglia; Andrea Taormina; Vincenzo Azzarello; Filippo Felice; Annamaria Martino; Salvatore Paterna; Pietro Di Pasquale
Journal:  Int J Cardiovasc Imaging       Date:  2006-11-16       Impact factor: 2.316
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.